Premas Life Sciences Pvt. Ltd.

- The iSeq 100 Sequencing System makes next-generation sequencing easier and more affordable than ever. Designed for simplicity, it allows labs of all sizes to sequence DNA and RNA at the push of a button. “iSEQ100” with unbelievable low capex. Leveraging the speed and affordability of complementary metal- oxide-semiconductor (CMOS) technology and the accuracy of sequencing by synthesis (SBS) chemistry, the iSeq 100 System enables virtually any lab to acquire powerful next-generation sequencing (NGS) technology.

- Lucigen manufacture and sell over 325 biomedical research products to life-science and healthcare professionals worldwide. Lucigen leverages its expertise in enzyme evolution and core competencies that support a variety of applications such as synthetic biology, next gen sequencing, and human diagnostics.  Lucigen’s acquisition of Epicentre products expanded our portfolio offering into array-based analysis, in vitro transcription, nucleic-acid extraction purification, and transposon mutagenesis. As an ISO 13485-certified company, we proudly offer catalog and custom solutions to meet researchers’ expanding needs, including OEM partnerships.

- Biomatrica is a United States-based biotechnology company that develops chemicals for ambient temperature preservation of biological materials for the purpose of expanding the availability and accuracy of medical diagnostics and research. Specifically, the company focuses on improving the stability of biological materials, such as DNA, RNA, proteins, cells from patient samples used in research, and diagnostic testing reagents. Biomatrica has developed alternatives to existing preservation technologies, such as cold storage and lyophilization (freeze-drying), to prevent degradation of perishable biological materials. Biomatrica's technologies are used in applications such as pre-analytic sample collection, diagnostic assays, biobanking, forensics, and basic research

Premas Life sciences who anendeavors to bring to researchers and innovation focused organizations cutting edge tools for applications across human health, agriculture, pharma, environment, forensics, energy and much more. This market is growing by CAGR of 18.2% and estimated to grow by 22.7% till 2022 in India. Total business of Premas is yearly is worth 128 Crore and it is growing its business by rate of 27% annually. With the advent of the era of genomics, leveraging the latest technology to gain an edge in mining and interpreting information has become imperative. With our ensemble range of products, we facilitate to answer the vital questions of people’s research using some of the smartest tools from across the world. Our dynamic portfolio of leading global technologies boasts of some of the most exciting genomics and cell biology applications. We believe that life sciences research is powering healthcare innovations today. With the advent of data science and machine learning, life sciences takes a whole new turn as processing large sums of data becomes faster and automated. We are on a mission to help Indian researchers and innovators gain access to novel technologies and connect the missing links in their research. We want to join hands with local distributors which has good hold in their territory in the market segment of Healthcare, Clinical, Diagnostics, Universities, Biotech colleges, Pharma, agriculture and fitness and Hospitals.